FDA issues update on heart device recall

Jun 09, 2022 - 03:16 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration yesterday released an update on Medtronic’s recall of 1,614 devices used to pump blood from the heart to the rest of the body because the devices may malfunction. The notice updates affected models of the Heartware Ventricular Assist Device System and recommended actions. Medtronic initiated the recall in April due to a pump weld defect.

Related News Articles

Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
FDA advises against using plastic syringes made in China
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
FDA adds vaporized hydrogen peroxide as an established medical device sterilization method 
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…
Headline
FDA updates sterilization standards for medical device makers
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…
Headline
AHA urges EPA to ensure ethylene oxide standards don’t disrupt supply chain
Commenting yesterday on the Environmental Protection Agency’s proposed standards for ethylene oxide use to sterilize medical devices, AHA encouraged the agency…